6640--Specimen Validity and Drug of Abuse of Abuse Reagent Supplies for the Minneapolis VA Health Care Systemview on SAM.gov

The Department of Veterans Affairs, Network Contracting Office 23 intends to award a sole source contract under the authority of FAR 6.103-1/FAR Overhaul 12.102(a) Only one responsible source and no other supplies will satisfy agency requirements, to Siemens Healthcare Diagnostics, Inc. for FDA approved specimen validity and Fentanyl reagents. These reagents will be used to verify the validity of specimens, including nitrite and creatinine assays, as well as perform Fentanyl testing in our highly specialized Forensic Toxicology Laboratory. This notice of intent is not a request for quotations; interested parties may express their interest by providing a capabilities statement no later than September 11, 2026, at 16:00 CT. The capabilities statement must provide clear and unambiguous evidence to substantiate the capability of the party to provide the required services. A determination not to compete this proposed contract upon responses to this notice is solely within the discretion of the Government. Verbal responses are not acceptable and will not be considered. When responding to this announcement, respondents should refer to Announcement, Notice of Intent. If after September 11, 2026 no viable responses have been received in response to this announcement, Department of Veterans Affairs shall negotiate solely with Siemens Healthcare Diagnostics, Inc. This notice of intent to award a sole source contract is not a request for competitive quotes. There will be no solicitation available for competitive quotes. Phone calls will not be accepted. The point of contact for this action is Contract Specialist Tess Thunder, who can be reached at theresa.thunder@va.gov. See attached document: P09 Final-Statement of Work.